Anna Engelen

Biotransformation of Finerenone, a Novel Nonsteroidal Mineralocorticoid Receptor Antagonist, in Dogs, Rats, and Humans, In Vivo and In Vitro

Michael Gerisch, Roland Heinig, Anna Engelen et al. · Drug Metabolism and Disposition · 2018 · 69 citations · Full text

Pharmacokinetics of the Novel, Selective, Non-steroidal Mineralocorticoid Receptor Antagonist Finerenone in Healthy Volunteers: Results from an Absolute Bioavailability Study and Drug–Drug Interaction Studies In Vitro and In Vivo

Roland Heinig, Michael Gerisch, Anna Engelen et al. · European Journal of Drug Metabolism and Pharmacokinetics · 2018 · 42 citations

Molecular Pharmacology, Pharmacological Study, Healthy Volunteers +8

Metabolism and Disposition of the Novel Oral Factor XIa Inhibitor Asundexian in Rats and in Humans

Isabel Piel, Anna Engelen, Dieter Lang et al. · European Journal of Drug Metabolism and Pharmacokinetics · 2023 · 17 citations · Full text

Pharmacokinetics of asundexian with combined CYP3A and P‐gp inhibitors and an inducer: Target in vitro and in vivo studies

Friederike Kanefendt, Christine Brase, Natalia A. Jungmann et al. · British Journal of Clinical Pharmacology · 2023 · 12 citations · Full text